Kamada Ltd. - Ordinary Shares (NQ:KMDA)

7.770 -0.060 (-0.77%)

Delayed Quote Updated: 3:01 PM EDT, Oct 16, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Kamada Ltd. - Ordinary Shares

< Previous 1 2 3 Next >

Kamada Targets $205M Revenue as Plasma Therapies, Kedrab Demand Fuel Growth ↗

September 27, 2026

Kamada (NASDAQ:KMDA) outlined its growth strategy, product portfolio and financial outlook during a company presentation, emphasizing demand for specialty plasma-derived therapies and a plan to expand...

Via MarketBeat

Kamada (KMDA) Q2 2026 Earnings Call Transcript ↗

August 19, 2026

KEDRAB sales and distribution expansion drive record revenue and EBITDA growth.

Via The Motley Fool

Topics Earnings

Kamada Q2 Earnings Call Highlights ↗

August 12, 2026

Kamada (NASDAQ:KMDA) reported record revenue and adjusted EBITDA for the second quarter and first half of 2026, driven by higher sales of its specialty plasma-derived products, including KEDRAB,...

Via MarketBeat

Topics Earnings

Kamada Ltd (NASDAQ:KMDA) Reports Record 2025 Results Despite Q4 Earnings Miss ↗

March 11, 2026

Via Chartmill

Earnings Scheduled For November 10, 2025 ↗

November 10, 2025

Via Benzinga

An Overview of Kamada's Earnings ↗

November 07, 2025

Via Benzinga

An Overview of Kamada's Earnings ↗

August 12, 2025

Via Benzinga

Kamada (KMDA) Q1 2026 Earnings Transcript ↗

May 13, 2026

Kamada (KMDA) Q1 2026 Earnings Transcript

Via The Motley Fool

Kamada Q1 Earnings Call Highlights ↗

May 13, 2026

Kamada (NASDAQ:KMDA) reiterated its full-year 2026 outlook after reporting first-quarter results that management said were in line with expectations, excluding a temporary shipment delay that shifted...

Via MarketBeat

Topics Earnings

Kamada Targets 13% Revenue Growth And 23% Adjusted EBITDA Growth In 2026 Driven By Its Diverse Commercial Portfolio

January 13, 2026

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Kamada Targets 13% Revenue Growth And 23% Adjusted EBITDA Growth In 2026 Driven By Its Diverse Commercial Portfolio

January 13, 2026

Via TheNewswire.com

Earnings Preview For Kamada ↗

May 13, 2025

Via Benzinga

Kamada Reports Strongest Quarter For The Year In Q3, With Over 30% Profitability Increase Year-Over-Year

November 18, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Kamada Reports Strongest Quarter For The Year In Q3, With Over 30% Profitability Increase Year-Over-Year

November 18, 2025

Via TheNewswire.com

Kamada (KMDA) Q3 2025 Earnings Call Transcript ↗

November 10, 2025

Kamada (KMDA) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

KAMADA LTD (NASDAQ:KMDA) Reports Mixed Q3 2025 Results with Revenue Beat and Pre-Market Surge ↗

November 10, 2025

Kamada (KMDA) Q3 2025 earnings show revenue beat estimates, driving a positive market reaction. The company reported strong year-over-year growth in sales and profitability.

Via Chartmill

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

October 01, 2025

Via Benzinga

KAMADA LTD (NASDAQ:KMDA) Reports Mixed Q2 2025 Earnings with Strong EPS Beat and Raised Profitability Guidance ↗

August 13, 2025

Kamada Ltd (KMDA) reported mixed Q2 2025 earnings, with revenue slightly below estimates but EPS beating forecasts. Stock rose pre-market as profitability outlook improved.

Via Chartmill

Kamada Q1 Results: Double-Digit Growth, Company Reiterates Guidance As It Hits Multiple Milestones Including Plasma Business Expansion

June 11, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Kamada Q1 Results: Double-Digit Growth, Company Reiterates Guidance As It Hits Multiple Milestones Including Plasma Business Expansion

June 11, 2025

Via TheNewswire.com

Earnings Scheduled For August 13, 2025 ↗

August 13, 2025

Via Benzinga

Kamada Wants To Do More For Organ Transplant Patients, Increases Efforts To Build Awareness Of Its CMV Treatment CYTOGAM

June 06, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Kamada Wants To Do More For Organ Transplant Patients, Increases Efforts To Build Awareness Of Its CMV Treatment CYTOGAM

June 06, 2025

Via TheNewswire.com

Kamada Expects Third Plasma Collection Site To Support Its Hyper-Immune Plasma Needs And Add Up To $10M In Annual Revenue At Full Capacity

April 22, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Earnings Scheduled For May 14, 2025 ↗

May 14, 2025

Via Benzinga

Kamada Expects Third Plasma Collection Site To Support Its Hyper-Immune Plasma Needs And Add Up To $10M In Annual Revenue At Full Capacity

April 22, 2025

By Meg Flippin Benzinga

Via TheNewswire.com

Kamada Is Bringing Relief To Those With Rare And Serious Conditions

April 16, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Kamada Is Bringing Relief To Those With Rare And Serious Conditions

April 16, 2025

Via TheNewswire.com

Sidoti Events, LLC's Virtual March Small-Cap Conference

March 18, 2025

Via ACCESS Newswire

Incyte, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

March 17, 2025

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.